The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

NCT05696392 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

47

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated due to lack of enrollment.

Conditions

Atopic Dermatitis

Interventions

DRUG: ruxolitinib cream

Sponsor

Incyte Corporation